Trachoma Epidemiology and Control Strategies

Trachoma, the leading infectious cause of blindness worldwide, is initiated by recurrent ocular infection with Chlamydia trachomatis. It predominantly affects children in impoverished, resource-limited settings, with transmission favoured by overcrowding, poor facial hygiene and inadequate water and sanitation. Repeated infections provoke conjunctival inflammation, progressive scarring, in-turned eyelashes (trachomatous trichiasis) and corneal opacity leading to visual impairment. Geographic mapping has revealed persistent high-burden areas in sub-Saharan Africa, parts of Asia and the Middle East, despite global declines in prevalence driven by socioeconomic gains and targeted interventions. The World Health Organization aims to eliminate trachoma as a public health problem by 2030 under its global roadmap.

Control is guided by the SAFE strategy: surgical correction of trichiasis, mass drug administration of antibiotics (primarily azithromycin), promotion of facial cleanliness and environmental improvements such as water, sanitation and hygiene. Surgery reduces morbidity, antibiotic distribution curbs active infection, and hygiene and environmental measures interrupt transmission cycles. Traditional monitoring relies on clinical grading and PCR detection of ocular C. trachomatis, while recent advances include serological surveillance, digital imaging with telemedicine and mathematical modelling to refine intervention thresholds. Key challenges remain in sustaining high coverage, addressing antibiotic resistance and tailoring strategies to low-prevalence settings, emphasising the need for integrated, community-based health programmes.

Research from Nature Portfolio

Recent studies have validated serological assays targeting anti-Pgp3 antibodies in children as robust indicators of transmission intensity. Age-seroprevalence curves mirror community infection levels, rising steeply under high transmission and flattening near elimination thresholds. A defined seroprevalence cut-off effectively identifies clusters with ongoing ocular Chlamydia trachomatis circulation, offering a scalable surveillance tool to augment or replace resource-intensive PCR and clinical grading, particularly in settings approaching elimination.

Trachoma Epidemiology and Control Strategies publication trend

The graph below shows the total number of articles in trachoma epidemiology and control strategies across all publications each year (not limited to Nature Index journals).

Technical terms

SAFE strategy: Integrated approach comprising Surgery, Antibiotics, Facial cleanliness and Environmental improvement to eliminate trachoma.

Mass drug administration (MDA): Periodic distribution of antibiotics to entire at-risk populations to reduce infection prevalence.

Seroprevalence: Proportion of individuals with detectable antibodies against a pathogen in a population.

Seroconversion rate: Rate at which susceptible individuals develop pathogen-specific antibodies per unit time.

Trachomatous inflammation—follicular (TF): Early clinical sign of trachoma characterised by the presence of follicles on the tarsal conjunctiva.

Trachomatous trichiasis (TT): Advanced disease stage where eyelashes turn inwards and abrade the cornea, risking blindness.

References

1. Trachoma: global magnitude of a preventable cause of blindness. British Journal of Ophthalmology (2008).
2. Monitoring transmission intensity of trachoma with serology. Nature Communications (2023).
3. A Virtual Reading Center Model Using Crowdsourcing to Grade Photographs for Trachoma: Validation Study. Journal of Medical Internet Research (2023).
4. The prevention and management of postoperative trachomatous trichiasis: A systematic review. Survey of Ophthalmology (2023).
5. Effect of Water, Sanitation, and Hygiene on the Prevention of Trachoma: A Systematic Review and Meta-Analysis. PLOS Medicine (2014).